» Articles » PMID: 34638632

Phospho-Tau and Chromatin Landscapes in Early and Late Alzheimer's Disease

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Oct 13
PMID 34638632
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Cellular identity is determined through complex patterns of gene expression. Chromatin, the dynamic structure containing genetic information, is regulated through epigenetic modulators, mainly by the histone code. One of the main challenges for the cell is maintaining functionality and identity, despite the accumulation of DNA damage throughout the aging process. Replicative cells can remain in a senescent state or develop a malign cancer phenotype. In contrast, post-mitotic cells such as pyramidal neurons maintain extraordinary functionality despite advanced age, but they lose their identity. This review focuses on tau, a protein that protects DNA, organizes chromatin, and plays a crucial role in genomic stability. In contrast, tau cytosolic aggregates are considered hallmarks of Alzheimer´s disease (AD) and other neurodegenerative disorders called tauopathies. Here, we explain AD as a phenomenon of chromatin dysregulation directly involving the epigenetic histone code and a progressive destabilization of the tau-chromatin interaction, leading to the consequent dysregulation of gene expression. Although this destabilization could be lethal for post-mitotic neurons, tau protein mediates profound cellular transformations that allow for their temporal survival.

Citing Articles

Multi Layered Omics Approaches Reveal Glia Specific Alterations in Alzheimer's Disease: A Systematic Review and Future Prospects.

Is O, Min Y, Wang X, Oatman S, Abraham Daniel A, Ertekin-Taner N Glia. 2024; 73(3):539-573.

PMID: 39652363 PMC: 11784841. DOI: 10.1002/glia.24652.


Exploring the neuroprotective potential of Nrf2-pathway activators against annonacin toxicity.

Costa M, Rosler T, Hoglinger G Sci Rep. 2024; 14(1):20123.

PMID: 39209951 PMC: 11362529. DOI: 10.1038/s41598-024-70837-1.


Nuclear face of Tau: an inside player in neurodegeneration.

Younas N, Saleem T, Younas A, Zerr I Acta Neuropathol Commun. 2023; 11(1):196.

PMID: 38087392 PMC: 10714511. DOI: 10.1186/s40478-023-01702-x.


Structural and functional damage to neuronal nuclei caused by extracellular tau oligomers.

Sun X, Eastman G, Shi Y, Saibaba S, Oliveira A, Lukens J Alzheimers Dement. 2023; 20(3):1656-1670.

PMID: 38069673 PMC: 10947977. DOI: 10.1002/alz.13535.


Lamivudine (3TC), a Nucleoside Reverse Transcriptase Inhibitor, Prevents the Neuropathological Alterations Present in Mutant Tau Transgenic Mice.

Valles-Saiz L, Avila J, Hernandez F Int J Mol Sci. 2023; 24(13).

PMID: 37446327 PMC: 10342792. DOI: 10.3390/ijms241311144.


References
1.
Ohno M, Ando T, Priest D, Kumar V, Yoshida Y, Taniguchi Y . Sub-nucleosomal Genome Structure Reveals Distinct Nucleosome Folding Motifs. Cell. 2019; 176(3):520-534.e25. DOI: 10.1016/j.cell.2018.12.014. View

2.
Nativio R, Donahue G, Berson A, Lan Y, Amlie-Wolf A, Tuzer F . Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease. Nat Neurosci. 2018; 21(4):497-505. PMC: 6124498. DOI: 10.1038/s41593-018-0101-9. View

3.
Frost B, Hemberg M, Lewis J, Feany M . Tau promotes neurodegeneration through global chromatin relaxation. Nat Neurosci. 2014; 17(3):357-66. PMC: 4012297. DOI: 10.1038/nn.3639. View

4.
Trojer P, Reinberg D . Facultative heterochromatin: is there a distinctive molecular signature?. Mol Cell. 2007; 28(1):1-13. DOI: 10.1016/j.molcel.2007.09.011. View

5.
Tang S . Chromatin Organization by Repetitive Elements (CORE): A Genomic Principle for the Higher-Order Structure of Chromosomes. Genes (Basel). 2014; 2(3):502-15. PMC: 3927610. DOI: 10.3390/genes2030502. View